Literature DB >> 11894122

Fibroblasts capture cathepsin D secreted by breast cancer cells: possible role in the regulation of the invasive process.

N Heylen1, L-M Vincent, V Devos, V Dubois, C Remacle, A Trouet.   

Abstract

Breast cancer cells oversecrete the lysosomal peptidase cathepsin D as a pro-enzyme. In this study, we assessed the effect of media conditioned by MRC-5 fibroblasts or MCF-7/6 breast cancer cells on cathepsin D (CD) production and secretion by these two cell types. We also considered the influence of estrogens and matrix components (type I or type IV collagen, or Matrigel) on the expression and activity of CD produced by breast cancer cells of different invasive potentials (MCF-7/AZ, MCF-7/6, MDA-MB-231). In our system, fibroblasts conditioned medium does not significantly affect CD levels produced and secreted by the MCF-7/6 cells. However, we found that fibroblasts are able to capture the pro-CD secreted by these tumor cells by a mannose 6-phosphate-dependent process. We also found a positive correlation between the proportion of extracellular CD levels and the invasive potentials of the tumor cell types considered. If estrogens are able to upregulate CD production and secretion by receptor-positive cells, it is not the case of extracellular matrix components. On the other hand, our results indicate that matrix components are able to influence the distribution of the different CD forms in and out of the cells. Our data suggest that tumor fibroblasts, by enhancing their intracellular CD levels, could assist cancer cells in the digestion of extracellular matrix during the invasion of tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11894122     DOI: 10.3892/ijo.20.4.761

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

1.  Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.

Authors:  D Nikolić-Vukosavljević; M Markićević; G Grujić-Adanja; A Petrović; K Kanjer; Z Nesković-Konstantinović
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.

Authors:  Mélanie Beaujouin; Christine Prébois; Danielle Derocq; Valérie Laurent-Matha; Olivier Masson; Sophie Pattingre; Peter Coopman; Nadir Bettache; Jami Grossfield; Robert E Hollingsworth; Hongyu Zhang; Zemin Yao; Bradley T Hyman; Peter van der Geer; Gary K Smith; Emmanuelle Liaudet-Coopman
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

3.  Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma.

Authors:  Ozge Alper; William G Stetler-Stevenson; Lyndsay N Harris; Wolfgang W Leitner; Metin Ozdemirli; Dan Hartmann; Mark Raffeld; Mones Abu-Asab; Stephen Byers; Zhengping Zhuang; Edward H Oldfield; Yanhe Tong; Elke Bergmann-Leitner; Wayne E Criss; Koichi Nagasaki; Samuel C Mok; Daniel W Cramer; F Seyda Karaveli; Raphaela Goldbach-Mansky; Paul Leo; Kurt Stromberg; Robert J Weil
Journal:  Cancer Sci       Date:  2009-06-17       Impact factor: 6.716

4.  Catalytically inactive human cathepsin D triggers fibroblast invasive growth.

Authors:  Valérie Laurent-Matha; Sharon Maruani-Herrmann; Christine Prébois; Mélanie Beaujouin; Murielle Glondu; Agnès Noël; Marie Luz Alvarez-Gonzalez; Sylvia Blacher; Peter Coopman; Stephen Baghdiguian; Christine Gilles; Jadranka Loncarek; Gilles Freiss; Françoise Vignon; Emmanuelle Liaudet-Coopman
Journal:  J Cell Biol       Date:  2005-01-24       Impact factor: 10.539

5.  Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.

Authors:  Anne-Sophie Bach; Danielle Derocq; Valérie Laurent-Matha; Philippe Montcourrier; Salwa Sebti; Béatrice Orsetti; Charles Theillet; Céline Gongora; Sophie Pattingre; Eva Ibing; Pascal Roger; Laetitia K Linares; Thomas Reinheckel; Guillaume Meurice; Frank J Kaiser; Christian Gespach; Emmanuelle Liaudet-Coopman
Journal:  Oncotarget       Date:  2015-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.